RECRUITING

An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial tests an individualized online home-based exercise program in gynecologic cancer survivors and its impact on gut microbiome (the bacteria and microorganisms that live in the digestive system) and symptoms such as pain, fatigue, sleep disturbance, depression, and cognitive impairment. These symptoms can significantly reduce the quality of life (QoL) and survival rate in this cancer population. Thus, promoting physical activity among cancer survivors may help mitigate these severe symptoms. Using online platforms such as Zoom can help participants access an individualized exercise program that meets their specific needs to engage in physical activity and decrease their symptom burden. Home-based exercise, by providing self-chosen time and location and low costs, can address some barriers to physical activity for cancer survivors. An individualized online home-based exercise program may be feasible, and may improve symptoms and quality of life in gynecologic cancer survivors.

Official Title

Feasibility and Acceptability of an Individualized Online Home-Based Exercise Program on Psychoneurological Symptoms in Gynecologic Cancer Survivors: A Pilot Study

Quick Facts

Study Start:2025-09-01
Study Completion:2027-07-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06709534

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Women aged ≥ 18 years old
  2. * Previously diagnosed with gynecologic cancer (e.g., uterine, ovarian, cervical)
  3. * Completed cancer treatment (chemotherapy or chemoradiation)
  4. * Able to read and speak English
  5. * Do not meet recommended exercise levels as defined by The American College of Sports Medicine
  1. * History of metastatic or other primary cancer
  2. * Serious mental health conditions (e.g., bipolar disorder, schizophrenia, major depression)
  3. * Certain chronic diseases (e.g., muscular-skeletal diseases that limit mobility, autoimmune diseases, uncontrolled diabetes, hypertension, renal disease (creatinine \> 2.5 mg/dL)
  4. * Unable to read/speak English

Contacts and Locations

Study Contact

Zahra Barandouzi, Ph.D.,MSN,RN
CONTACT
4045449078
zahra.barandouzi@emory.edu

Principal Investigator

Zahra A Barandouzi, Ph.D.,MSN,RN
PRINCIPAL_INVESTIGATOR
Emory University Hospital/Winship Cancer Institute

Study Locations (Sites)

Grady Health System
Atlanta, Georgia, 30303
United States
Emory University Hospital Midtown
Atlanta, Georgia, 30308
United States
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322
United States
Emory Decatur Hospital
Decatur, Georgia, 30033
United States

Collaborators and Investigators

Sponsor: Emory University

  • Zahra A Barandouzi, Ph.D.,MSN,RN, PRINCIPAL_INVESTIGATOR, Emory University Hospital/Winship Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-09-01
Study Completion Date2027-07-30

Study Record Updates

Study Start Date2025-09-01
Study Completion Date2027-07-30

Terms related to this study

Additional Relevant MeSH Terms

  • Malignant Female Reproductive System Neoplasm